Cost Benefit of Removing the Penicillin Allergy Label from Nonallergic Patients

20:46 EDT 11 May 2018 | NEJM

Besides avoiding broad-spectrum antibiotic use, “delabeling” children as penicillin-allergic resulted in significant antibiotic cost savings for families.

Cost Benefit of Removing the Penicillin Allergy Label from Nonallergic Patients

More From BioPortfolio on "Cost Benefit of Removing the Penicillin Allergy Label from Nonallergic Patients"